Volume 1917, Issue 1

Search all Reactions Weekly articles

July 2022

July 30, 2022

Filter by

Volume:

Sort by

Date published:

New to old Old to new

586 articles in this issue

Amphotericin-B-liposomal/fluconazole

Case report 30 July 2022 Pages: 51 - 51
Amphotericin-B/flucytosine

Case report 30 July 2022 Pages: 52 - 52
Amphotericin-b/posaconazole

Case report 30 July 2022 Pages: 53 - 53
Ampicillin/sulbactam

Case report 30 July 2022 Pages: 54 - 54
Analgesics/lamotrigine/steroids

Case report 30 July 2022 Pages: 55 - 55
Anti-CD20-monoclonal-antibody/immune-globulin

Case report 30 July 2022 Pages: 56 - 56
Antibacterials

Case report 30 July 2022 Pages: 57 - 57
Antibacterials/cefalexin

Case report 30 July 2022 Pages: 58 - 58
Antibacterials/dexamethasone/furosemide

Case report 30 July 2022 Pages: 59 - 59
Antibacterials/steroids/rituximab

Case report 30 July 2022 Pages: 60 - 60
Antibiotics/enoxaparin sodium

Case report 30 July 2022 Pages: 61 - 61
Anticoagulants/hydrogen-peroxide

Case report 30 July 2022 Pages: 62 - 62
Antiepileptic drugs/methylprednisolone

Case report 30 July 2022 Pages: 63 - 63
Antiepileptic drugs/vitamins

Case report 30 July 2022 Pages: 64 - 64
Antifungals/anti-inflammatories/remdesivir

Case report 30 July 2022 Pages: 65 - 65
Antifungals/immunosuppressants

Case report 30 July 2022 Pages: 66 - 66
Antihypertensive/selexipag

Case report 30 July 2022 Pages: 67 - 67
Antihypotensives/remimazolam

Case report 30 July 2022 Pages: 68 - 68
Antilymphocyte-globulin/antithymocyte-globulin

Case report 30 July 2022 Pages: 69 - 69
Antimicrobial drugs

Case report 30 July 2022 Pages: 70 - 70
Antineoplastics

Case report 30 July 2022 Pages: 71 - 71
Antineoplastics

Case report 30 July 2022 Pages: 72 - 72
Antineoplastics

Case report 30 July 2022 Pages: 73 - 73
Antineoplastics

Case report 30 July 2022 Pages: 74 - 74
Antineoplastics

Case report 30 July 2022 Pages: 75 - 75
Antineoplastics

Case report 30 July 2022 Pages: 76 - 76
Antineoplastics

Case report 30 July 2022 Pages: 77 - 77
Antineoplastics

Case report 30 July 2022 Pages: 78 - 78
Antineoplastics

Case report 30 July 2022 Pages: 79 - 79
Antineoplastics

Case report 30 July 2022 Pages: 80 - 80
Antineoplastics

Case report 30 July 2022 Pages: 81 - 81
Antineoplastics

Case report 30 July 2022 Pages: 82 - 82
Antineoplastics

Case report 30 July 2022 Pages: 83 - 83
Antineoplastics

Case report 30 July 2022 Pages: 84 - 84
Antineoplastics

Case report 30 July 2022 Pages: 85 - 85
Antineoplastics

Case report 30 July 2022 Pages: 86 - 86
Antineoplastics

Case report 30 July 2022 Pages: 87 - 87
Antineoplastics/ciclosporin

Case report 30 July 2022 Pages: 88 - 88
Antipsychotics

Case report 30 July 2022 Pages: 89 - 89
Antithymocyte-globulin/basiliximab

Case report 30 July 2022 Pages: 90 - 90
Antivirals

Case report 30 July 2022 Pages: 91 - 91
Apixaban

Case report 30 July 2022 Pages: 92 - 92
Apixaban/rivaroxaban/warfarin

Case report 30 July 2022 Pages: 93 - 93
Apremilast/guselkumab

Case report 30 July 2022 Pages: 94 - 94
Asparaginase

Case report 30 July 2022 Pages: 95 - 95
Asparaginase

Case report 30 July 2022 Pages: 96 - 96
Aspirin/enoxaparin sodium/rivaroxaban

Case report 30 July 2022 Pages: 97 - 97
Aspirin/heparin/prasugrel

Case report 30 July 2022 Pages: 98 - 98
Aspirin/warfarin

Case report 30 July 2022 Pages: 99 - 99
Atenolol/propranolol

Case report 30 July 2022 Pages: 100 - 100

Volume 1917, Issue 1

Search

Navigation